TNF-α inhibitor reverse the effects of human umbilical cord-derived stem cells on experimental arthritis by increasing immunosuppression

Cellular Immunology

Volumn 273, Issue 1, 2012, Pages 30-40

  Wu, Cheng Chi ^a   Wu, Tzu Chin ^a   Liu, Fei Lan ^a   Sytwu, Huey Kang ^a   Chang, Deh Ming ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Cartilage repair; Collagen induced arthritis (CIA); Human umbilical cord derived stem cells (HUCSCs); Immunogenicity; Rheumatoid arthritis (RA)

Indexed keywords

5' NUCLEOTIDASE; CD161 ANTIGEN; CELL THERAPY AGENT; COLLAGENASE 3; ENDOGLIN; ETANERCEPT; GELATINASE B; HERMES ANTIGEN; HLA ANTIGEN CLASS 1; HLA G ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; THY 1 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BONE DEVELOPMENT; CARTILAGE DEGENERATION; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL INFILTRATION; CHONDROGENESIS; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE COURSE; DRUG POTENCY; DRUG POTENTIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOGENICITY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; TH17 CELL;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CARTILAGE; CELL DIFFERENTIATION; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED DBA; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL CORD;

MUS;

EID: 84855990157     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.11.009     Document Type: Article

References (37)

1. Feldmann M., Brennan F.M., Maini R.N. Rheumatoid arthritis. Cell 1996, 85:307-310.
2. Song C., Luo L., Lei Z., Li B., Liang Z., Liu G., Li D., Zhang G., Huang B., Feng Z.H. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J. Immunol. 2008, 181:6117-6124.
3. McInnes I.B., Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 2007, 7:429-442.
4. Olsen N.J., Stein C.M. New drugs for rheumatoid arthritis. N. Engl. J. Med. 2004, 350:2167-2179.
5. Yen B.L., Chang C.J., Liu K.J., Chen Y.C., Hu H.I., Bai C.H., Yen M.L. Brief report-human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes. Stem Cells 2009, 27:451-456.
6. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
7. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
8. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., Grisanti S., Gianni A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
9. Abdi R., Fiorina P., Adra C.N., Atkinson M., Sayegh M.H. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes 2008, 57:1759-1767.
10. Wang Y., Zhang A., Ye Z., Xie H., Zheng S. Bone marrow-derived mesenchymal stem cells inhibit acute rejection of rat liver allografts in association with regulatory T-cell expansion. Transplant. Proc. 2009, 41:4352-4356.
11. Augello A., Tasso R., Negrini S.M., Cancedda R., Pennesi G. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum. 2007, 56:1175-1186.
12. Gonzalez M.A., Gonzalez-Rey E., Rico L., Buscher D., Delgado M. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum. 2009, 60:1006-1019.
13. Menier C., Rabreau M., Challier J.C., Le Discorde M., Carosella E.D., Rouas-Freiss N. Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. Blood 2004, 104:3153-3160.
14. LeMaoult J., Zafaranloo K., Le Danff C., Carosella E.D. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J. 2005, 19:662-664.
15. Diaz-Lagares A., Alegre E., Arroyo A., Corrales F.J., Gonzalez A. Tyrosine nitration in the human leucocyte antigen-G-binding domain of the Ig-like transcript 2 protein. FEBS J. 2009, 276:4233-4243.
16. Nasef A., Mathieu N., Chapel A., Frick J., Francois S., Mazurier C., Boutarfa A., Bouchet S., Gorin N.C., Thierry D., Fouillard L. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 2007, 84:231-237.
17. Selmani Z., Naji A., Gaiffe E., Obert L., Tiberghien P., Rouas-Freiss N., Carosella E.D., Deschaseaux F. HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells. Transplantation 2009, 87:S62-S66.
18. Campioni D., Rizzo R., Stignani M., Melchiorri L., Ferrari L., Moretti S., Russo A., Bagnara G.P., Bonsi L., Alviano F., Lanzoni G., Cuneo A., Baricordi O.R., Lanza F. A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs. Cytometry B Clin. Cytom. 2009, 76:225-230.
19. Yoo K.H., Jang I.K., Lee M.W., Kim H.E., Yang M.S., Eom Y., Lee J.E., Kim Y.J., Yang S.K., Jung H.L., Sung K.W., Kim C.W., Koo H.H. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell. Immunol. 2009, 259:150-156.
20. Weiss M.L., Anderson C., Medicetty S., Seshareddy K.B., Weiss R.J., VanderWerff I., Troyer D., McIntosh K.R. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 2008, 26:2865-2874.
21. Baksh D., Yao R., Tuan R.S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007, 25:1384-1392.
22. Guillot P.V., De Bari C., Dell'Accio F., Kurata H., Polak J., Fisk N.M. Comparative osteogenic transcription profiling of various fetal and adult mesenchymal stem cell sources. Differentiation 2008, 76:946-957.
23. Karahuseyinoglu S., Cinar O., Kilic E., Kara F., Akay G.G., Demiralp D.O., Tukun A., Uckan D., Can A. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 2007, 25:319-331.
24. Brand D.D., Latham K.A., Rosloniec E.F. Collagen-induced arthritis. Nat. Protoc. 2007, 2:1269-1275.
25. Carlin R., Davis D., Weiss M., Schultz B., Troyer D. Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod. Biol. Endocrinol. 2006, 4:8.
26. Cho P.S., Messina D.J., Hirsh E.L., Chi N., Goldman S.N., Lo D.P., Harris I.R., Popma S.H., Sachs D.H., Huang C.A. Immunogenicity of umbilical cord tissue derived cells. Blood 2008, 111:430-438.
27. Djouad F., Fritz V., Apparailly F., Louis-Plence P., Bony C., Sany J., Jorgensen C., Noel D. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum. 2005, 52:1595-1603.
28. Chen B., Hu J., Liao L., Sun Z., Han Q., Song Z., Zhao R.C. Flk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6. Clin. Exp. Immunol. 2010, 159:292-302.
29. Wolchok J.D., Vilcek J. Induction of HLA class I mRNA by cytokines in human fibroblasts: comparison of TNF, IL-1 and IFN-beta. Cytokine 1992, 4:520-527.
30. Spaggiari G.M., Capobianco A., Becchetti S., Mingari M.C., Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006, 107:1484-1490.
31. Koga H., Shimaya M., Muneta T., Nimura A., Morito T., Hayashi M., Suzuki S., Ju Y.J., Mochizuki T., Sekiya I. Local adherent technique for transplanting mesenchymal stem cells as a potential treatment of cartilage defect. Arthritis Res. Ther. 2008, 10:R84.
32. Devine S.M., Bartholomew A.M., Mahmud N., Nelson M., Patil S., Hardy W., Sturgeon C., Hewett T., Chung T., Stock W., Sher D., Weissman S., Ferrer K., Mosca J., Deans R., Moseley A., Hoffman R. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp. Hematol. 2001, 29:244-255.
33. Ponte A.L., Marais E., Gallay N., Langonne A., Delorme B., Herault O., Charbord P., Domenech J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25:1737-1745.
34. Biton J., Semerano L., Delavallee L., Lemeiter D., Laborie M., Grouard-Vogel G., Boissier M.C., Bessis N. Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis. J. Immunol. 2011, 186:3899-3910.
35. Valencia X., Stephens G., Goldbach-Mansky R., Wilson M., Shevach E.M., Lipsky P.E. TNF down modulates the function of human CD4+CD25hi T-regulatory cells. Blood 2006, 108:253-261.
36. Choi J.J., Yoo S.A., Park S.J., Kang Y.J., Kim W.U., Oh I.H., Cho C.S. Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. Clin. Exp. Immunol. 2008, 153:269-276.
37. Katsikis P.D., Chu C.Q., Brennan F.M., Maini R.N., Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J. Exp. Med. 1994, 179:1517-1527.